David W Keiser - Net Worth and Insider Trading

David W Keiser Net Worth

The estimated net worth of David W Keiser is at least $55 Million dollars as of 2024-05-04. David W Keiser is the Director of Alexion Pharmaceuticals Inc and owns about 299,092 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $55 Million. Details can be seen in David W Keiser's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David W Keiser has not made any transactions after 2009-06-01 and currently still holds the listed stock(s).

Transaction Summary of David W Keiser

To

David W Keiser Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David W Keiser owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of David W Keiser’s form 4 insider trades.

Insider Ownership Summary of David W Keiser

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2009-06-01 director

David W Keiser Latest Holdings Summary

David W Keiser currently owns a total of 1 stock. David W Keiser owns 299,092 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 1, 2009, with a value of $55 Million.

Latest Holdings of David W Keiser

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2009-06-01 299,092 182.50 54,584,290

Holding Weightings of David W Keiser


David W Keiser Form 4 Trading Tracker

According to the SEC Form 4 filings, David W Keiser has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 100,000 shares on June 1, 2009, which brought David W Keiser around $2 Million.

Insider Trading History of David W Keiser

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David W Keiser Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David W Keiser Ownership Network

Ownership Network List of David W Keiser

No Data

Ownership Network Relation of David W Keiser


David W Keiser Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

David W Keiser is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

David W Keiser Mailing Address

Above is the net worth, insider trading, and ownership report for David W Keiser. You might contact David W Keiser via mailing address: C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire Ct 06410.

Discussions on David W Keiser

No discussions yet.